Key result
Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.
Why the study?
Does colchicine improve outcomes and prevent recurrence in patients with acute pericarditis?
Does colchicine improve outcomes and prevent recurrence in patients with acute pericarditis?
Answers are grounded in this paper and cite their sources.
Colchicine is recommended as a first-line therapy for acute pericarditis and prevention of recurrence.
Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.
No takes yet. Share an insight, caveat, or question.
Saltzman et al. (2007) studied this question. Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.
Synapse has enriched 10 related papers. Consider them for comparative context: